Assessment of alopecia areata universalis successfully treated with upadacitinib
International Journal of Dermatology · 2023-02 · 62 (2)
DOI: 10.1111/ijd.16342 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 02.07.2022. Verfasst von Niccolò Gori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Alopecia Areata. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
- Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
ORCID-Profile: Niccolò Gori, Alessandro Di Stefani, Andrea Chiricozzi
Zitieren
APA
Gori, N., Cappilli, S., Di Stefani, A., Tassone, F., Chiricozzi, A., & Peris, K. (2023). Assessment of alopecia areata universalis successfully treated with upadacitinib. International Journal of Dermatology, 62(2). https://doi.org/10.1111/ijd.16342
Vancouver
Gori N, Cappilli S, Di Stefani A, Tassone F, Chiricozzi A, Peris K. Assessment of alopecia areata universalis successfully treated with upadacitinib. International Journal of Dermatology. 2023;62(2). doi:10.1111/ijd.16342
BibTeX
@article{Gori2023,
author = {Gori, Niccolò and Cappilli, Simone and Di Stefani, Alessandro and Tassone, Francesco and Chiricozzi, Andrea and Peris, Ketty},
title = {Assessment of alopecia areata universalis successfully treated with upadacitinib},
journal = {International Journal of Dermatology},
year = {2023},
volume = {62},
number = {2},
doi = {10.1111/ijd.16342}
}
EUVIMED